An excess of the Rsf-1 gene may play an important role in the development of ovarian cancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotyping technique to identify "subchromosomal alterations," the researchers observed an overproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressive forms of ovarian cancer. These results were not seen in any of the low-grade ovarian cancers.
Because this was the first study to identify this genetic alteration, the new finding may lead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerous cell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings of the National Academy of Sciences (September 27, 2005).
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs